ProteoXyme
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
ProteoXyme (XYMOGEN), a food supplement au code-barres 871149004071, is described by its US market label, recorded on 24 January 2024. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 24 January 2024. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149004071
- Form
- Capsule
- One serving
- 5 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Gellan Gum, Water, Inulin, Stearic Acid, Magnesium Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Pancreatin 10X | Blend | 500 mg |
| Protease, Pancreatic | Enzyme | not stated |
| Amylase, Pancreatic | Enzyme | not stated |
| Lipase, Pancreatic | Enzyme | not stated |
| Rutin | Other substance | 250 mg |
| Bromelain | Enzyme | 225 mg |
| Trypsin Complex | Blend | 150 mg |
| Trypsin | Enzyme | not stated |
| Chymotrypsin | Enzyme | not stated |
| Papain | Enzyme | 114 mg |
| Serrapeptase | Enzyme | 27 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: ProteoXyme
Entered into DSLD on 26 December 2020. Retirée du marché américain le 8 September 2023 (selon le DSLD).- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Trypsin Complex (150 mg)
- Different quantity per serving : Papain: 300 mg in this version; 114 mg on the displayed label
- Different quantity per serving : Serrapeptase: 99 mg in this version; 27 mg on the displayed label
- Different unit, without conversion : Chymotrypsin: 37.5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Trypsin: 125 mg in this version; quantity not stated on the displayed label
Official label: ProteoXyme
Entered into DSLD on 25 January 2017. Retirée du marché américain le 29 April 2019 (selon le DSLD).- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Trypsin Complex (150 mg)
- Different quantity per serving : Papain: 300 mg in this version; 114 mg on the displayed label
- Different quantity per serving : Serrapeptase: 99 mg in this version; 27 mg on the displayed label
- Different unit, without conversion : Chymotrypsin: 37.5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Trypsin: 125 mg in this version; quantity not stated on the displayed label
Official label: ProteoXyme
Entered into DSLD on 25 August 2015. Retirée du marché américain le 20 September 2016 (selon le DSLD).- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Trypsin Complex (150 mg)
- Different quantity per serving : Papain: 300 mg in this version; 114 mg on the displayed label
- Different quantity per serving : Serrapeptase: 99 mg in this version; 27 mg on the displayed label
- Different unit, without conversion : Chymotrypsin: 37.5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Trypsin: 125 mg in this version; quantity not stated on the displayed label
Official label: ProteoXyme
Entered into DSLD on 10 October 2014. Retirée du marché américain le 15 September 2014 (selon le DSLD).- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Trypsin Complex (150 mg)
- Different quantity per serving : Papain: 300 mg in this version; 114 mg on the displayed label
- Different quantity per serving : Serrapeptase: 99 mg in this version; 27 mg on the displayed label
- Different unit, without conversion : Chymotrypsin: 37.5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Trypsin: 125 mg in this version; quantity not stated on the displayed label
Official label: ProteoXyme
Entered into DSLD on 24 December 2013. Retirée du marché américain le 11 October 2012 (selon le DSLD).- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Trypsin Complex (150 mg)
- Different unit, without conversion : Bromelain: 540 GDU in this version; 225 mg on the displayed label
- Different unit, without conversion : Chymotrypsin: 37,500 USP in this version; quantity not stated on the displayed label
- Different unit, without conversion : Pancreatin 10X: 125,000 USP in this version; 500 mg on the displayed label
- Different unit, without conversion : Papain: 4,000,000 PU in this version; 114 mg on the displayed label
- Different unit, without conversion : Serrapeptase: 60,000 U in this version; 27 mg on the displayed label
- Different unit, without conversion : Trypsin: 288,000 USP in this version; quantity not stated on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : XYMOGEN